BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 24373781)

  • 1. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study.
    van der Voort EA; Koehler EM; Dowlatshahi EA; Hofman A; Stricker BH; Janssen HL; Schouten JN; Nijsten T
    J Am Acad Dermatol; 2014 Mar; 70(3):517-24. PubMed ID: 24373781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients.
    Kagansky N; Levy S; Keter D; Rimon E; Taiba Z; Fridman Z; Berger D; Knobler H; Malnick S
    Liver Int; 2004 Dec; 24(6):588-94. PubMed ID: 15566509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India.
    Madanagobalane S; Anandan S
    Australas J Dermatol; 2012 Aug; 53(3):190-7. PubMed ID: 22672067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population.
    Perez M; Gonzáles L; Olarte R; Rodríguez NI; Tabares M; Salazar JP; Jaimes S; García RG; López-Jaramillo P
    Prev Med; 2011 Feb; 52(2):174-7. PubMed ID: 21147154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and nonalcoholic fatty liver disease in a Spanish population: influence of the diagnostic criteria used.
    Caballería L; Pera G; Rodríguez L; Auladell MA; Bernad J; Canut S; Torán P
    Eur J Gastroenterol Hepatol; 2012 Sep; 24(9):1007-11. PubMed ID: 22668875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.
    Bedogni G; Miglioli L; Masutti F; Tiribelli C; Marchesini G; Bellentani S
    Hepatology; 2005 Jul; 42(1):44-52. PubMed ID: 15895401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
    Miele L; Vallone S; Cefalo C; La Torre G; Di Stasi C; Vecchio FM; D'Agostino M; Gabrieli ML; Vero V; Biolato M; Pompili M; Gasbarrini G; Rapaccini G; Amerio P; De Simone C; Grieco A
    J Hepatol; 2009 Oct; 51(4):778-86. PubMed ID: 19664838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
    Sanyal AJ; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Stravitz RT; Mills AS
    Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.
    Koller T; Kollerova J; Hlavaty T; Huorka M; Payer J
    Scand J Gastroenterol; 2012 Feb; 47(2):197-203. PubMed ID: 22182015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.
    Dassanayake AS; Kasturiratne A; Rajindrajith S; Kalubowila U; Chakrawarthi S; De Silva AP; Makaya M; Mizoue T; Kato N; Wickremasinghe AR; de Silva HJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1284-8. PubMed ID: 19476560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease.
    Friis-Liby I; Aldenborg F; Jerlstad P; Rundström K; Björnsson E
    Scand J Gastroenterol; 2004 Sep; 39(9):864-9. PubMed ID: 15513385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease.
    Church TS; Kuk JL; Ross R; Priest EL; Biltoft E; Blair SN
    Gastroenterology; 2006 Jun; 130(7):2023-30. PubMed ID: 16762625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
    Gisondi P; Targher G; Zoppini G; Girolomoni G
    J Hepatol; 2009 Oct; 51(4):758-64. PubMed ID: 19560226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study.
    Xu X; Su L; Gao Y; Ding Y
    PLoS One; 2017; 12(1):e0169952. PubMed ID: 28099469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Prevalence of Advanced Liver Fibrosis in Patients with Psoriasis: A Cross-sectional Analysis from the Rotterdam Study.
    van der Voort EA; Koehler EM; Nijsten T; Stricker BH; Hofman A; Janssen HL; Schouten JN; Wakkee M
    Acta Derm Venereol; 2016 Feb; 96(2):213-7. PubMed ID: 26062958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.
    Wong VW; Chu WC; Wong GL; Chan RS; Chim AM; Ong A; Yeung DK; Yiu KK; Chu SH; Woo J; Chan FK; Chan HL
    Gut; 2012 Mar; 61(3):409-15. PubMed ID: 21846782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome.
    Yilmaz Y; Senates E; Ayyildiz T; Colak Y; Tuncer I; Ovunc AO; Dolar E; Kalayci C
    Eur J Clin Invest; 2012 Apr; 42(4):411-8. PubMed ID: 21913918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase.
    López-Suárez A; Guerrero JM; Elvira-González J; Beltrán-Robles M; Cañas-Hormigo F; Bascuñana-Quirell A
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):1011-7. PubMed ID: 21915061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic Fatty Liver Disease Is Associated With QT Prolongation in the General Population.
    Hung CS; Tseng PH; Tu CH; Chen CC; Liao WC; Lee YC; Chiu HM; Lin HJ; Ho YL; Yang WS; Wu MS; Chen MF
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26199227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.